NEW YORK (GenomeWeb News) — GenomeQuest said today it is licensing its sequence search technology to Migenix, a Vancouver, BC-based drug developer.
The company, formerly known as Gene-IT, said Migenix will use its GenomeQuest product in its clinical programs, which include drug candidates for hepatitis C, catheter-related infections, and dermatological diseases.